SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ACADIA Pharmaceuticals Inc (ACAD)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
588 32 0 ACAD
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
363>>Are you asking if 103 might also lock the receptor into its inactive fortuck-11/18/2006
362Short cargo bed.... not interested in the practical aspects of a dual cab, onscaram(o)uche-11/18/2006
361"Shopping for a four wheel drive Tacoma today. Somebody stop me." Havdr.praveen-11/18/2006
360First, the abstract appears to be a bit screwed up..... the first-stated intscaram(o)uche-11/18/2006
359[Inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonistuck-11/17/2006
358I have been a shareholder for a little while. Here's something of interest.Tom Caruthers-11/8/2006
357ACADIA Pharmaceuticals Reports Third Quarter 2006 Financial Results Monday Novemmopgcw-11/6/2006
356bizarre..... if that were an EPO application, I wouldn't worry about the lscaram(o)uche-10/28/2006
355Well, if it was just Brann acting out, he sure used a lot of other company scientuck-10/28/2006
354Usually, it's scientific founder not getting along with CEO........ sciscaram(o)uche-10/28/2006
353the cynic in me says its acad nepotism for bad-boy brann after getting tainted wmopgcw-10/28/2006
352>> Anyone got thoughts? << Not like the old days, when I knew the sscaram(o)uche-10/28/2006
351ACADIA Pharmaceuticals to Support Launch of New Company Focused on Substance Abusim1-10/23/2006
350Clinical & Research News Drug Firms Vie to Develop More Effective Antipsychodr.praveen-10/22/2006
349Thanks! Didn't see it earlier.kenhott-10/9/2006
348Second-Generation Antipsychotic Medications Appear to Offer Little Advantage Ovedr.praveen-10/3/2006
347oooops! Kenhott..... been out and about, away from compie. Wanted to be awascaram(o)uche-10/2/2006
346ACADIA Pharmaceuticals Announces Accelerated Timing of ACP-103 Phase II Trial inmopgcw-9/28/2006
345Hey where have you been? Everyone is pretty quiet. Feels like detention. Takekenhott-9/19/2006
344Beat ya! Message 22801193 Cheers, Tucktuck-9/18/2006
343Mol Pharmacol. 2006 Sep 14; [Epub ahead of print] Structural Requirements of Tscaram(o)uche-9/17/2006
342[Pharmacology and signaling properties of EGFR isoforms studied by Bioluminescentuck-9/15/2006
341[Pharmacology and signaling properties of EGFR isoforms studied by Bioluminescentuck-9/15/2006
340Here's a description of the original verdict: employerslawyer.blogspot.comBiomaven-9/13/2006
339"To fully settle the litigation inclusive of all fees and costs, pursuant tdr.praveen-9/12/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News